Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers

2009 ◽  
Vol 205 (1) ◽  
pp. 85-91 ◽  
Author(s):  
Jamie Horder ◽  
Philip J. Cowen ◽  
Martina Di Simplicio ◽  
Michael Browning ◽  
Catherine J. Harmer
BJPsych Open ◽  
2020 ◽  
Vol 6 (6) ◽  
Author(s):  
Catherine Hobbs ◽  
Susannah E. Murphy ◽  
Lucy Wright ◽  
James Carson ◽  
Indra Van Assche ◽  
...  

Background Depression is characterised by negative views of the self. Antidepressant treatment may remediate negative self-schema through increasing processing of positive information about the self. Changes in affective processing during social interactions may increase expression of prosocial behaviours, improving interpersonal communications. Aims To examine whether acute administration of citalopram is associated with an increase in positive affective learning biases about the self and prosocial behaviour. Method Healthy volunteers (n = 41) were randomised to either an acute 20 mg dose of citalopram or matched placebo in a between-subjects double-blind design. Participants completed computer-based cognitive tasks designed to measure referential affective processing, social cognition and expression of prosocial behaviours. Results Participants administered citalopram made more cooperative choices than those administered placebo in a prisoner's dilemma task (β = 20%, 95% CI: 2%, 37%). Exploratory analyses indicated that participants administered citalopram showed a positive bias when learning social evaluations about a friend (β = 4.06, 95% CI: 0.88, 7.24), but not about the self or a stranger. Similarly, exploratory analyses found evidence of increased recall of positive words and reduced recall of negative words about others (β = 2.41, 95% CI: 0.89, 3.93), but not the self, in the citalopram group. Conclusions Participants administered citalopram showed greater prosocial behaviours, increased positive recall and increased positive learning of social evaluations towards others. The increase in positive affective bias and prosocial behaviours towards others may, at least partially, be a mechanism of antidepressant effect. However, we found no evidence that citalopram influenced self-referential processing.


2021 ◽  
Vol 53 (06) ◽  
pp. 402-407
Author(s):  
Tuuli Sedman ◽  
Vallo Volke ◽  
Keiu Heinla ◽  
Eero Vasar

AbstractGlucagon-like peptide 1 receptor agonists (GLP-1 RAs) are antidiabetic drugs with effects beyond antihyperglycemic action. The aim of the study was to examine whether a single dose of exenatide could be used as a stimulation test for the pituitary-adrenal axis. We carried out a single-group, open-label pilot clinical trial in an ambulatory setting. Ten healthy volunteers of both sexes with body weight>65 kg and age between 18–50 years were recruited. After fasting for 12 hours the subjects received 10 μg of exenatide solution subcutaneously. Blood samples were taken before the administration of exenatide and up to 150 minutes thereafter. The primary outcome was the maximal level of cortisol after the administration of exenatide. Single administration of exenatide 10 μg resulted in a modest increase in ACTH and cortisol levels, as compared to untreated values, and a decrease in blood glucose levels. Remarkably, a robust suppression of both renin and aldosterone levels occurred. We showed that acute administration of exenatide in a full therapeutic dose modestly stimulates the hypothalamic-pituitary-adrenal axis but inhibits the renin-aldosterone system. Further research is warranted to confirm this finding in the placebo-controlled study.


Endocrinology ◽  
2010 ◽  
Vol 151 (8) ◽  
pp. 3720-3727 ◽  
Author(s):  
Helen C. Atkinson ◽  
James D. Leggett ◽  
Susan A. Wood ◽  
Emma S. Castrique ◽  
Yvonne M. Kershaw ◽  
...  

We have examined the effects of acute administration of the cannabinoid receptor type 1 (CB1) antagonist AM251 on the rat hypothalamic-pituitary-adrenal (HPA) axis with respect to both gender and time of day. Blood samples were collected from conscious male and female rats every 5 min using an automated blood sampling system, and corticosterone concentrations were determined. In male rats, there was a distinct diurnal effect of AM251 with a greater activation of the HPA axis in the morning (diurnal trough) compared with the evening (diurnal peak). At both times of the day, circulating corticosterone concentrations were elevated for approximately 4 h after AM251 administration. In female rats, there was also diurnal variation in the activation of the HPA axis; however, these effects were not as profound as those in males. Corticosterone concentrations were only slightly elevated at the diurnal trough and for a shorter time period than in males (2 compared with 4 h). Moreover, there was no effect of AM251 on corticosterone concentrations when administered at the diurnal peak. Subsequent studies, only in males, in which both ACTH and corticosterone were measured, confirmed that the effects of AM251 on corticosterone were mediated by ACTH. Moreover, the elevation of both ACTH and corticosterone could be replicated using another CB1 antagonist, AM281. These data demonstrate that the extent and duration of HPA axis activation after CB1 blockade are clearly dependent on both gender and time of day.


2019 ◽  
Vol 32 (1) ◽  
Author(s):  
Hannelore Geysen ◽  
Eva Gielis ◽  
Eveline Deloose ◽  
Tim Vanuytsel ◽  
Jan Tack ◽  
...  

2008 ◽  
Vol 62 (5) ◽  
pp. 610-616 ◽  
Author(s):  
Kunihiro Iwamoto ◽  
Yukiko Kawamura ◽  
Masahiro Takahashi ◽  
Yuji Uchiyama ◽  
Kazutoshi Ebe ◽  
...  

1992 ◽  
Vol 15 ◽  
pp. 591B ◽  
Author(s):  
A. Broocks ◽  
T. Pigott ◽  
S. Canter ◽  
J. Hill ◽  
D. L. Murphy

Sign in / Sign up

Export Citation Format

Share Document